This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

Ingrid Kelly
Partner at Xista Science Ventures


Ingrid Kelly is a Partner and member of the investment team at xista science ventures, a VC fund that invests in early stage deeptech and life science academic spinoffs in Austria, DACH and beyond.

Following completion of a PhD in molecular biology from the University of Cambridge, Ingrid qualified as a European Patent Attorney and worked for several years in the pharma industry. Since 2012 she has been actively involved in technology transfer, initially at the University of Vienna and subsequently at IST Austria; in this role she supports researchers in the life sciences, identifying promising innovations and guiding them through to out-licensing and spin-off creation.

Agenda Sessions

  • Translational funds – a new player in the early stage venture capital market in Europe